Nektar Therapeutics Reports First Quarter 2022 Financial Results

Go back to Nektar Therapeutics Reports First Quarter 2022 Financial Results
Nektar Therapeutics (NASDAQ: NKTR) Delayed: 73.58 -2.5 (3.29%)
Previous Close $76.08    52 Week High $19.98 
Open $76.08    52 Week Low $10.52 
Day High $76.53    P/E N/A 
Day Low $73.19    EPS $-1.45 
Volume 228,774